329 related articles for article (PubMed ID: 31264265)
1. Monocyte and macrophage subtypes as paired cell biomarkers for coronary artery disease.
Arnold KA; Blair JE; Paul JD; Shah AP; Nathan S; Alenghat FJ
Exp Physiol; 2019 Sep; 104(9):1343-1352. PubMed ID: 31264265
[TBL] [Abstract][Full Text] [Related]
2. Increased proatherogenic monocyte-platelet cross-talk in monocyte subpopulations of patients with stable coronary artery disease.
Czepluch FS; Kuschicke H; Dellas C; Riggert J; Hasenfuss G; Schäfer K
J Intern Med; 2014 Feb; 275(2):144-54. PubMed ID: 24118494
[TBL] [Abstract][Full Text] [Related]
3. Circulating CD14+CD16+ monocyte subsets as biomarkers of the severity of coronary artery disease in patients with stable angina pectoris.
Ozaki Y; Imanishi T; Taruya A; Aoki H; Masuno T; Shiono Y; Komukai K; Tanimoto T; Kitabata H; Akasaka T
Circ J; 2012; 76(10):2412-8. PubMed ID: 22785372
[TBL] [Abstract][Full Text] [Related]
4. A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement.
Trombetta AC; Soldano S; Contini P; Tomatis V; Ruaro B; Paolino S; Brizzolara R; Montagna P; Sulli A; Pizzorni C; Smith V; Cutolo M
Respir Res; 2018 Sep; 19(1):186. PubMed ID: 30249259
[TBL] [Abstract][Full Text] [Related]
5. Circulating CD14
Meeuwsen JAL; de Vries JJ; van Duijvenvoorde A; van der Velden S; van der Laan SW; van Koeverden ID; van de Weg SM; de Borst GJ; de Winther MPJ; Kuiper J; Pasterkamp G; Hoefer IE; de Jager SCA;
J Mol Cell Cardiol; 2019 Feb; 127():260-269. PubMed ID: 30629987
[TBL] [Abstract][Full Text] [Related]
6. CD14
Urbanski K; Ludew D; Filip G; Filip M; Sagan A; Szczepaniak P; Grudzien G; Sadowski J; Jasiewicz-Honkisz B; Sliwa T; Kapelak B; McGinnigle E; Mikolajczyk T; Guzik TJ
Thromb Haemost; 2017 May; 117(5):971-980. PubMed ID: 28229168
[TBL] [Abstract][Full Text] [Related]
7. Small high-density lipoprotein is associated with monocyte subsets in stable coronary artery disease.
Krychtiuk KA; Kastl SP; Pfaffenberger S; Pongratz T; Hofbauer SL; Wonnerth A; Katsaros KM; Goliasch G; Gaspar L; Huber K; Maurer G; Dostal E; Oravec S; Wojta J; Speidl WS
Atherosclerosis; 2014 Dec; 237(2):589-96. PubMed ID: 25463093
[TBL] [Abstract][Full Text] [Related]
8. Differential polarization and the expression of efferocytosis receptor MerTK on M1 and M2 macrophages isolated from coronary artery disease patients.
Mohd Idrus FN; Ahmad NS; Hoe CH; Azlan M; Norfuad FA; Yusof Z; Wan Isa WYH; Mohamed Ali AA; Yvonne-Tee GB
BMC Immunol; 2021 Mar; 22(1):21. PubMed ID: 33761885
[TBL] [Abstract][Full Text] [Related]
9. Human Blood Monocyte Subsets: A New Gating Strategy Defined Using Cell Surface Markers Identified by Mass Cytometry.
Thomas GD; Hamers AAJ; Nakao C; Marcovecchio P; Taylor AM; McSkimming C; Nguyen AT; McNamara CA; Hedrick CC
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1548-1558. PubMed ID: 28596372
[TBL] [Abstract][Full Text] [Related]
10. Monocyte subset distribution in patients with stable atherosclerosis and elevated levels of lipoprotein(a).
Krychtiuk KA; Kastl SP; Hofbauer SL; Wonnerth A; Goliasch G; Ozsvar-Kozma M; Katsaros KM; Maurer G; Huber K; Dostal E; Binder CJ; Pfaffenberger S; Oravec S; Wojta J; Speidl WS
J Clin Lipidol; 2015; 9(4):533-41. PubMed ID: 26228671
[TBL] [Abstract][Full Text] [Related]
11. Single Cell High Dimensional Analysis of Human Peripheral Blood Mononuclear Cells Reveals Unique Intermediate Monocyte Subsets Associated with Sex Differences in Coronary Artery Disease.
Chatterjee N; Komaravolu RK; Durant CP; Wu R; McSkimming C; Drago F; Kumar S; Valentin-Guillama G; Miller YI; McNamara CA; Ley K; Taylor A; Alimadadi A; Hedrick CC
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474140
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of human monocytes: an optimized four-color flow cytometry protocol for analysis of monocyte subsets.
Tallone T; Turconi G; Soldati G; Pedrazzini G; Moccetti T; Vassalli G
J Cardiovasc Transl Res; 2011 Apr; 4(2):211-9. PubMed ID: 21308491
[TBL] [Abstract][Full Text] [Related]
13. Impact of CD14
Yamamoto H; Yoshida N; Shinke T; Otake H; Kuroda M; Sakaguchi K; Hirota Y; Toba T; Takahashi H; Terashita D; Uzu K; Tahara N; Shinkura Y; Kuroda K; Nagasawa Y; Nagano Y; Tsukiyama Y; Yanaka KI; Emoto T; Sasaki N; Yamashita T; Ogawa W; Hirata KI
Atherosclerosis; 2018 Feb; 269():245-251. PubMed ID: 29407600
[TBL] [Abstract][Full Text] [Related]
14. Infliximab therapy increases the frequency of circulating CD16(+) monocytes and modifies macrophage cytokine response to bacterial infection.
Nazareth N; Magro F; Silva J; Duro M; Gracio D; Coelho R; Appelberg R; Macedo G; Sarmento A
Clin Exp Immunol; 2014 Sep; 177(3):703-11. PubMed ID: 24816497
[TBL] [Abstract][Full Text] [Related]
15. Subgroups of monocytes predict cardiovascular events in patients with coronary heart disease. The PHAMOS trial (Prospective Halle Monocytes Study).
Höpfner F; Jacob M; Ulrich C; Russ M; Simm A; Silber RE; Girndt M; Noutsias M; Werdan K; Schlitt A
Hellenic J Cardiol; 2019; 60(5):311-321. PubMed ID: 31055050
[TBL] [Abstract][Full Text] [Related]
16. Monocyte-macrophage polarization balance in pre-diabetic individuals.
Fadini GP; Cappellari R; Mazzucato M; Agostini C; Vigili de Kreutzenberg S; Avogaro A
Acta Diabetol; 2013 Dec; 50(6):977-82. PubMed ID: 24085683
[TBL] [Abstract][Full Text] [Related]
17. CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels.
Schlitt A; Heine GH; Blankenberg S; Espinola-Klein C; Dopheide JF; Bickel C; Lackner KJ; Iz M; Meyer J; Darius H; Rupprecht HJ
Thromb Haemost; 2004 Aug; 92(2):419-24. PubMed ID: 15269840
[TBL] [Abstract][Full Text] [Related]
18. Suppression of inflammatory signaling in monocytes from patients with coronary artery disease.
Schirmer SH; Fledderus JO; van der Laan AM; van der Pouw-Kraan TC; Moerland PD; Volger OL; Baggen JM; Böhm M; Piek JJ; Horrevoets AJ; van Royen N
J Mol Cell Cardiol; 2009 Feb; 46(2):177-85. PubMed ID: 19059264
[TBL] [Abstract][Full Text] [Related]
19. Blood Monocyte Phenotype Fingerprint of Stable Coronary Artery Disease: A Cross-Sectional Substudy of SMARTool Clinical Trial.
Sbrana S; Campolo J; Clemente A; Bastiani L; Cecchettini A; Ceccherini E; Caselli C; Neglia D; Parodi O; Chiappino D; Smit JM; Scholte AJ; Pelosi G; Rocchiccioli S
Biomed Res Int; 2020; 2020():8748934. PubMed ID: 32802883
[TBL] [Abstract][Full Text] [Related]
20. The "Intermediate" CD14
Wildgruber M; Aschenbrenner T; Wendorff H; Czubba M; Glinzer A; Haller B; Schiemann M; Zimmermann A; Berger H; Eckstein HH; Meier R; Wohlgemuth WA; Libby P; Zernecke A
Sci Rep; 2016 Dec; 6():39483. PubMed ID: 27991581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
